167 related articles for article (PubMed ID: 21798026)
1. A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expression.
Meike S; Yamamori T; Yasui H; Eitaki M; Matsuda A; Morimatsu M; Fukushima M; Yamasaki Y; Inanami O
Mol Cancer; 2011 Jul; 10():92. PubMed ID: 21798026
[TBL] [Abstract][Full Text] [Related]
2. A novel anticancer ribonucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine, enhances radiation-induced cell death in tumor cells.
Inanami O; Iizuka D; Iwahara A; Yamamori T; Kon Y; Asanuma T; Matsuda A; Kashiwakura I; Kitazato K; Kuwabara M
Radiat Res; 2004 Dec; 162(6):635-45. PubMed ID: 15548113
[TBL] [Abstract][Full Text] [Related]
3. X irradiation induces the proapoptotic state independent of the loss of clonogenic ability in Chinese hamster V79 cells.
Iizuka D; Inanami O; Matsuda A; Kashiwakura I; Asanuma T; Kuwabara M
Radiat Res; 2005 Jul; 164(1):36-44. PubMed ID: 15966763
[TBL] [Abstract][Full Text] [Related]
4. Treatment combining X-irradiation and a ribonucleoside anticancer drug, TAS106, effectively suppresses the growth of tumor cells transplanted in mice.
Yasui H; Inanami O; Asanuma T; Iizuka D; Nakajima T; Kon Y; Matsuda A; Kuwabara M
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):218-28. PubMed ID: 17448876
[TBL] [Abstract][Full Text] [Related]
5. A Nucleoside Anticancer Drug, 1-(3-C-Ethynyl-β-D-Ribo-Pentofuranosyl)Cytosine, Induces Depth-Dependent Enhancement of Tumor Cell Death in Spread-Out Bragg Peak (SOBP) of Proton Beam.
Maeda K; Yasui H; Yamamori T; Matsuura T; Takao S; Suzuki M; Matsuda A; Inanami O; Shirato H
PLoS One; 2016; 11(11):e0166848. PubMed ID: 27875573
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIF-1alpha by the anticancer drug TAS106 enhances X-ray-induced apoptosis in vitro and in vivo.
Yasui H; Ogura A; Asanuma T; Matsuda A; Kashiwakura I; Kuwabara M; Inanami O
Br J Cancer; 2008 Nov; 99(9):1442-52. PubMed ID: 18854835
[TBL] [Abstract][Full Text] [Related]
7. A phosphorylation-deubiquitination cascade regulates the BRCA2-RAD51 axis in homologous recombination.
Luo K; Li L; Li Y; Wu C; Yin Y; Chen Y; Deng M; Nowsheen S; Yuan J; Lou Z
Genes Dev; 2016 Dec; 30(23):2581-2595. PubMed ID: 27941124
[TBL] [Abstract][Full Text] [Related]
8. BMS-345541 sensitizes MCF-7 breast cancer cells to ionizing radiation by selective inhibition of homologous recombinational repair of DNA double-strand breaks.
Wu L; Shao L; Li M; Zheng J; Wang J; Feng W; Chang J; Wang Y; Hauer-Jensen M; Zhou D
Radiat Res; 2013 Feb; 179(2):160-70. PubMed ID: 23259762
[TBL] [Abstract][Full Text] [Related]
9. A phthalimidoalkanamide derived novel DNMT inhibitor enhanced radiosensitivity of A549 cells by inhibition of homologous recombination of DNA damage.
Kang HC; Chie EK; Kim HJ; Kim JH; Kim IH; Kim K; Shin BS; Ma E
Invest New Drugs; 2019 Dec; 37(6):1158-1165. PubMed ID: 30793218
[TBL] [Abstract][Full Text] [Related]
10. Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)-cytosine, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity.
Hattori H; Tanaka M; Fukushima M; Sasaki T; Matsuda A
J Med Chem; 1996 Dec; 39(25):5005-11. PubMed ID: 8960561
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate-mediated inhibition of RAD51 expression and homologous recombination in cancer cells.
Du LQ; Du XQ; Bai JQ; Wang Y; Yang QS; Wang XC; Zhao P; Wang H; Liu Q; Fan FY
J Cancer Res Clin Oncol; 2012 May; 138(5):811-8. PubMed ID: 22274865
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of Radiosensitivity by Eurycomalactone in Human NSCLC Cells Through G₂/M Cell Cycle Arrest and Delayed DNA Double-Strand Break Repair.
Dukaew N; Konishi T; Chairatvit K; Autsavapromporn N; Soonthornchareonnon N; Wongnoppavich A
Oncol Res; 2020 Mar; 28(2):161-175. PubMed ID: 31727206
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Homologous Recombination and Promotion of Mutagenic Repair of DNA Double-Strand Breaks Underpins Arabinoside-Nucleoside Analogue Radiosensitization.
Magin S; Papaioannou M; Saha J; Staudt C; Iliakis G
Mol Cancer Ther; 2015 Jun; 14(6):1424-33. PubMed ID: 25840584
[TBL] [Abstract][Full Text] [Related]
14. Antitumor mechanisms and metabolism of the novel antitumor nucleoside analogues, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil.
Takatori S; Kanda H; Takenaka K; Wataya Y; Matsuda A; Fukushima M; Shimamoto Y; Tanaka M; Sasaki T
Cancer Chemother Pharmacol; 1999; 44(2):97-104. PubMed ID: 10412942
[TBL] [Abstract][Full Text] [Related]
15. DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity.
Kim HJ; Kim JH; Chie EK; Young PD; Kim IA; Kim IH
Radiat Oncol; 2012 Mar; 7():39. PubMed ID: 22429326
[TBL] [Abstract][Full Text] [Related]
16. The purine scaffold Hsp90 inhibitor PU-H71 sensitizes cancer cells to heavy ion radiation by inhibiting DNA repair by homologous recombination and non-homologous end joining.
Lee Y; Li HK; Masaoka A; Sunada S; Hirakawa H; Fujimori A; Nickoloff JA; Okayasu R
Radiother Oncol; 2016 Oct; 121(1):162-168. PubMed ID: 27666928
[TBL] [Abstract][Full Text] [Related]
17. The major DNA repair pathway after both proton and carbon-ion radiation is NHEJ, but the HR pathway is more relevant in carbon ions.
Gerelchuluun A; Manabe E; Ishikawa T; Sun L; Itoh K; Sakae T; Suzuki K; Hirayama R; Asaithamby A; Chen DJ; Tsuboi K
Radiat Res; 2015 Mar; 183(3):345-56. PubMed ID: 25738894
[TBL] [Abstract][Full Text] [Related]
18. An RNA-directed nucleoside anti-metabolite, 1-(3-C-ethynyl-beta-d-ribo-pentofuranosyl)cytosine (ECyd), elicits antitumor effect via TP53-induced Glycolysis and Apoptosis Regulator (TIGAR) downregulation.
Lui VW; Lau CP; Cheung CS; Ho K; Ng MH; Cheng SH; Hong B; Tsao SW; Tsang CM; Lei KI; Yamasaki Y; Mita A; Chan AT
Biochem Pharmacol; 2010 Jun; 79(12):1772-80. PubMed ID: 20219441
[TBL] [Abstract][Full Text] [Related]
19. TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation.
Lee Y; Sunada S; Hirakawa H; Fujimori A; Nickoloff JA; Okayasu R
Mol Cancer Ther; 2017 Jan; 16(1):16-24. PubMed ID: 28062703
[TBL] [Abstract][Full Text] [Related]
20. MEK inhibitor GSK1120212-mediated radiosensitization of pancreatic cancer cells involves inhibition of DNA double-strand break repair pathways.
Estrada-Bernal A; Chatterjee M; Haque SJ; Yang L; Morgan MA; Kotian S; Morrell D; Chakravarti A; Williams TM
Cell Cycle; 2015; 14(23):3713-24. PubMed ID: 26505547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
